Biohaven Pharmaceutical Holding Co Ltd (BHVN) - Total Liabilities

Latest as of March 2026: $336.91 Million USD

Based on the latest financial reports, Biohaven Pharmaceutical Holding Co Ltd (BHVN) has total liabilities worth $336.91 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Biohaven Pharmaceutical Holding Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Biohaven Pharmaceutical Holding Co Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Biohaven Pharmaceutical Holding Co Ltd's total liabilities have evolved over time, based on quarterly financial data.

Biohaven Pharmaceutical Holding Co Ltd Competitors by Total Liabilities

The table below lists competitors of Biohaven Pharmaceutical Holding Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Alkane Resources Ltd AU:ALK	Australia	AU$382.43 Million
Luolai Home Textile Co Ltd SHE:002293	China	CN¥2.53 Billion
Olaplex Holdings Inc NASDAQ:OLPX	USA	$582.21 Million
Gunkul Engineering Public Company Limited BK:GUNKUL	Thailand	฿16.68 Billion
Crombie Real Estate Investment Trust TO:CRR-UN	Canada	CA$2.68 Billion
Taiji Computer Corp Ltd SHE:002368	China	CN¥10.85 Billion
Peoples Bancorp Inc NASDAQ:PEBO	USA	$8.43 Billion
Gansu Jiu Steel Group Hongxing Iron & Steel Co Ltd SHG:600307	China	CN¥47.36 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Biohaven Pharmaceutical Holding Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BHVN stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.41	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.60	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.72	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biohaven Pharmaceutical Holding Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biohaven Pharmaceutical Holding Co Ltd (2017–2025)

The table below shows the annual total liabilities of Biohaven Pharmaceutical Holding Co Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	$399.38 Million	+108.36%
2024-12-31	$191.67 Million	+124.87%
2023-12-31	$85.24 Million	-30.71%
2022-12-31	$123.01 Million	+159.68%
2021-12-31	$47.37 Million	+36.44%
2020-12-31	$34.72 Million	-90.13%
2019-12-31	$351.69 Million	+152.85%
2018-12-31	$139.09 Million	+832.44%
2017-12-31	$14.92 Million	--

About Biohaven Pharmaceutical Holding Co Ltd

NYSE:BHVN USA Biotechnology

Market Cap

$2.05 Billion

Market Cap Rank

#7590 Global

#2256 in USA

Share Price

$13.63

Change (1 day)

-0.87%

52-Week Range

$7.79 - $18.11

All Time High

$59.75